GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hoechst Pakistan Ltd (KAR:HPL) » Definitions » EV-to-EBITDA

Hoechst Pakistan (KAR:HPL) EV-to-EBITDA : 5.79 (As of May. 17, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Hoechst Pakistan EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Hoechst Pakistan's enterprise value is ₨12,611 Mil. Hoechst Pakistan's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ₨2,177 Mil. Therefore, Hoechst Pakistan's EV-to-EBITDA for today is 5.79.

The historical rank and industry rank for Hoechst Pakistan's EV-to-EBITDA or its related term are showing as below:

KAR:HPL' s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.97   Med: 8.97   Max: 38.08
Current: 5.8

During the past 13 years, the highest EV-to-EBITDA of Hoechst Pakistan was 38.08. The lowest was 2.97. And the median was 8.97.

KAR:HPL's EV-to-EBITDA is ranked better than
85.9% of 709 companies
in the Drug Manufacturers industry
Industry Median: 14.88 vs KAR:HPL: 5.80

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-17), Hoechst Pakistan's stock price is ₨1434.05. Hoechst Pakistan's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₨109.260. Therefore, Hoechst Pakistan's PE Ratio for today is 13.13.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Hoechst Pakistan EV-to-EBITDA Historical Data

The historical data trend for Hoechst Pakistan's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hoechst Pakistan EV-to-EBITDA Chart

Hoechst Pakistan Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.47 6.13 4.53 10.30 8.08

Hoechst Pakistan Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.24 31.66 10.08 8.08 5.20

Competitive Comparison of Hoechst Pakistan's EV-to-EBITDA

For the Drug Manufacturers - General subindustry, Hoechst Pakistan's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hoechst Pakistan's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hoechst Pakistan's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Hoechst Pakistan's EV-to-EBITDA falls into.



Hoechst Pakistan EV-to-EBITDA Calculation

Hoechst Pakistan's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=12611.373/2177.353
=5.79

Hoechst Pakistan's current Enterprise Value is ₨12,611 Mil.
Hoechst Pakistan's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₨2,177 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hoechst Pakistan  (KAR:HPL) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Hoechst Pakistan's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1434.05/109.260
=13.13

Hoechst Pakistan's share price for today is ₨1434.05.
Hoechst Pakistan's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₨109.260.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Hoechst Pakistan EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Hoechst Pakistan's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Hoechst Pakistan (KAR:HPL) Business Description

Traded in Other Exchanges
N/A
Address
Korangi Industrial Area, Plot 23, Sector 22, Karachi, PAK, 74900
Hoechst Pakistan Ltd Formerly Sanofi-Aventis Pakistan Ltd is engaged in the manufacturing and selling of pharmaceutical and consumer healthcare products and vaccines. Its product profile includes Oral Anti-Diabetics, Emergency Care, Antibiotics, Anti-malaria, Epilepsy, Sleep Disorders, and others. Geographically, the company operates in Pakistan, Afghanistan, and others.

Hoechst Pakistan (KAR:HPL) Headlines

No Headlines